Cytori Therapeutics Inc Net Profit Margin 2006-2020 | PSTV

Cytori Therapeutics Inc net profit margin from 2006 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Cytori Therapeutics Inc Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-06-30 $0.01B $-0.00B -33.33%
2020-03-31 $0.01B $-0.01B -150.00%
2019-12-31 $0.01B $-0.01B -157.14%
2019-09-30 $0.01B $-0.01B -200.00%
2019-06-30 $0.00B $-0.02B -950.00%
2019-03-31 $0.00B $-0.01B -466.67%
2018-12-31 $0.00B $-0.02B -500.00%
2018-09-30 $0.00B $-0.02B -700.00%
2018-06-30 $0.00B $-0.02B -700.00%
2018-03-31 $0.00B $-0.02B -766.67%
2017-12-31 $0.00B $-0.03B -900.00%
2017-09-30 $0.00B $-0.02B -800.00%
2017-06-30 $0.00B $-0.02B -600.00%
2017-03-31 $0.00B $-0.02B -600.00%
2016-12-31 $0.00B $-0.02B -525.00%
2016-09-30 $0.01B $-0.02B -380.00%
2016-06-30 $0.01B $-0.01B -240.00%
2016-03-31 $0.01B $-0.00B -33.33%
2015-12-31 $0.01B $-0.02B -333.33%
2015-09-30 $0.01B $-0.02B -400.00%
2015-06-30 $0.01B $-0.04B -583.33%
2015-03-31 $0.01B $-0.05B -1020.00%
2014-12-31 $0.01B $-0.04B -760.00%
2014-09-30 $0.01B $-0.04B -683.33%
2014-06-30 $0.01B $-0.04B -528.57%
2014-03-31 $0.01B $-0.03B -400.00%
2013-12-31 $0.01B $-0.03B -371.43%
2013-09-30 $0.01B $-0.02B -250.00%
2013-06-30 $0.01B $-0.03B -371.43%
2013-03-31 $0.01B $-0.03B -387.50%
2012-12-31 $0.01B $-0.03B -400.00%
2012-09-30 $0.01B $-0.04B -583.33%
2012-06-30 $0.01B $-0.03B -457.14%
2012-03-31 $0.01B $-0.03B -414.29%
2011-12-31 $0.01B $-0.03B -457.14%
2011-09-30 $0.01B $-0.03B -485.71%
2011-06-30 $0.01B $-0.04B -514.29%
2011-03-31 $0.01B $-0.04B -514.29%
2010-12-31 $0.01B $-0.03B -325.00%
2010-09-30 $0.01B $-0.03B -371.43%
2010-06-30 $0.01B $-0.02B -383.33%
2010-03-31 $0.01B $-0.02B -380.00%
2009-12-31 $0.01B $-0.02B -460.00%
2009-09-30 $0.01B $-0.02B -420.00%
2009-06-30 $0.01B $-0.02B -350.00%
2009-03-31 $0.01B $-0.03B -466.67%
2008-12-31 $0.00B $-0.03B -750.00%
2008-09-30 $0.00B $-0.03B -1133.33%
2008-03-31 $0.00B $-0.03B -2800.00%
2007-12-31 $0.00B $-0.03B -2900.00%
2007-06-30 $0.00B $-0.02B -2400.00%
2007-03-31 $0.00B $-0.03B inf%
2006-12-31 $0.00B $-0.03B -2500.00%
2006-09-30 $0.00B $-0.04B -1850.00%
2006-06-30 $0.00B $-0.03B -750.00%
2006-03-31 $0.01B $-0.03B -560.00%
2005-12-31 $0.01B $-0.03B -433.33%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.011B $0.007B
Plus Therapeutics Inc. is a clinical-stage pharmaceutical company. It engages in developing treatments for cancer and other diseases primarily in the United States. The company's product candidate consists of DocePLUS which are in clinical stage. Plus Therapeutics Inc., formerly known as Cytori Therapeutics Inc., is based in Austin, Texas.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.197B 43.91
Takeda Pharmaceutical (TAK) Japan $52.178B 9.09
Astellas Pharma (ALPMY) Japan $25.637B 0.00
Eisai (ESALY) Japan $24.010B 20.29
UCB SA (UCBJF) Belgium $21.561B 0.00
Merck (MKGAF) Germany $20.291B 26.61
Ono Pharmaceutical (OPHLF) Japan $15.938B 28.18
Catalent (CTLT) United States $15.051B 48.92
Grifols, S.A (GRFS) Spain $12.307B 15.04
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.683B 25.17
Neurocrine Biosciences (NBIX) United States $9.339B 36.15
Jazz Pharmaceuticals (JAZZ) Ireland $8.294B 13.72
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.221B 0.00
IPSEN SA ADR (IPSEY) France $7.818B 0.00
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Ionis Pharmaceuticals (IONS) United States $6.563B 41.58
Arrowhead Pharmaceuticals (ARWR) United States $6.310B 0.00
Orion OYJ (ORINY) Finland $6.272B 21.76
United Therapeutics (UTHR) United States $5.480B 12.67
Evotec AG (EVTCY) Germany $4.517B 145.40
Sage Therapeutics (SAGE) United States $3.680B 0.00
ChemoCentryx (CCXI) United States $3.612B 0.00
PTC Therapeutics (PTCT) United States $3.606B 0.00
FibroGen (FGEN) United States $3.535B 0.00
Hypermarcas (HYPMY) Brazil $3.397B 12.49
Nektar Therapeutics (NKTR) United States $2.948B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.362B 11.43
Pacira BioSciences (PCRX) United States $2.253B 59.21
Xencor (XNCR) United States $2.221B 0.00
Revolution Medicines (RVMD) United States $2.170B 0.00
Corcept Therapeutics (CORT) United States $2.057B 18.94
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.030B 0.00
Cronos Group (CRON) Canada $1.952B 0.00
USANA Health Sciences (USNA) United States $1.762B 15.52
Ironwood Pharmaceuticals (IRWD) United States $1.536B 10.67
Heron Therapeutics (HRTX) United States $1.444B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.399B 13.34
Theravance Biopharma (TBPH) Cayman Islands $1.289B 0.00
Endo (ENDP) Ireland $1.257B 1.86
Trillium Therapeutics (TRIL) Canada $1.244B 0.00
Karyopharm Therapeutics (KPTI) United States $1.208B 0.00
Zogenix (ZGNX) United States $1.142B 0.00
Indivior (INVVY) United States $1.031B 12.78
CLINIGEN GP (CLIGF) United Kingdom $1.028B 0.00
Translate Bio (TBIO) United States $0.997B 0.00
ImmunoGen (IMGN) United States $0.962B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.903B 562.63
Esperion Therapeutics (ESPR) United States $0.874B 0.00
Vectura Group (VEGPF) United Kingdom $0.795B 0.00
Tilray (TLRY) Canada $0.711B 0.00
Ocular Therapeutix (OCUL) United States $0.691B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.655B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.647B 32.29
Radius Health (RDUS) United States $0.641B 0.00
Collegium Pharmaceutical (COLL) United States $0.634B 0.00
Flexion Therapeutics (FLXN) United States $0.613B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.601B 0.00
VAXART, INC (VXRT) United States $0.596B 0.00
Siga Technologies (SIGA) United States $0.507B 54.08
Spectrum Pharmaceuticals (SPPI) United States $0.497B 0.00
Ardelyx (ARDX) United States $0.471B 0.00
Molecular Templates (MTEM) United States $0.465B 0.00
Aerie Pharmaceuticals (AERI) United States $0.462B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.433B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.417B 0.00
Organogenesis Holdings (ORGO) United States $0.416B 0.00
Altimmune (ALT) United States $0.389B 0.00
Harpoon Therapeutics (HARP) United States $0.387B 0.00
TherapeuticsMD (TXMD) United States $0.376B 0.00
Redhill Biopharma (RDHL) Israel $0.364B 0.00
DURECT (DRRX) United States $0.359B 0.00
Concert Pharmaceuticals (CNCE) United States $0.351B 0.00
Profound Medical (PROF) Canada $0.347B 0.00
Akebia Therapeutics (AKBA) United States $0.347B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.323B 8.00
Innate Pharma SA (IPHYF) France $0.323B 0.00
MEI Pharma (MEIP) United States $0.318B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.312B 0.00
Jounce Therapeutics (JNCE) United States $0.307B 14.52
Menlo Therapeutics (VYNE) United States $0.302B 0.00
KalVista Pharmaceuticals (KALV) United States $0.282B 0.00
Lannett Co Inc (LCI) United States $0.268B 6.23
CASI Pharmaceuticals (CASI) United States $0.262B 0.00
Calithera Biosciences (CALA) United States $0.258B 0.00
Rafael Holdings (RFL) United States $0.245B 0.00
CTI BioPharma (CTIC) United States $0.240B 0.00
Xeris Pharmaceuticals (XERS) United States $0.237B 0.00
Aduro Biotech (KDNY) United States $0.235B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.224B 0.00
IMV INC (IMV) Canada $0.223B 0.00
Nature's Sunshine Products (NATR) United States $0.213B 21.02
Oasmia Pharmaceutical AB (OASMY) Sweden $0.211B 0.00
Nivalis Therapeutics (ALPN) United States $0.186B 0.00
Aquestive Therapeutics (AQST) United States $0.182B 0.00
Otonomy (OTIC) United States $0.179B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.177B 0.00
Taiwan Liposome (TLC) Taiwan $0.174B 0.00
Heat Biologics (HTBX) United States $0.174B 0.00
Aclaris Therapeutics (ACRS) United States $0.172B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.170B 0.00
OptiNose (OPTN) United States $0.161B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.158B 0.00
Champions Oncology (CSBR) United States $0.114B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.105B 0.00
MediWound (MDWD) Israel $0.096B 0.00
Lipocine (LPCN) United States $0.088B 0.00
Hemispherx BioPharma (AIM) United States $0.083B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.081B 0.00
ProPhase Labs (PRPH) United States $0.080B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.074B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.073B 0.00
ElectroCore (ECOR) United States $0.072B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.071B 0.00
AgeX Therapeutics (AGE) United States $0.071B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.070B 0.00
Novan (NOVN) United States $0.069B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.068B 0.00
Addex Therapeutics (ADXN) Switzerland $0.068B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.066B 0.00
Infinity Pharmaceuticals (INFI) United States $0.066B 0.00
Biomerica (BMRA) United States $0.064B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.063B 0.00
Natural Alternatives (NAII) United States $0.053B 0.00
SCYNEXIS (SCYX) United States $0.049B 0.00
India Globalization Capital (IGC) United States $0.048B 0.00
Onconova Therapeutics (ONTX) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 27.18
Forward Pharma (FWP) Denmark $0.045B 0.00
Recro Pharma (REPH) United States $0.044B 0.00
PolarityTE (PTE) United States $0.040B 0.00
Neos Therapeutics (NEOS) United States $0.034B 0.00
Mannatechorporated (MTEX) United States $0.033B 8.40
Bellicum Pharmaceuticals (BLCM) United States $0.032B 0.00
GTx (ONCT) United States $0.031B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.031B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.028B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.027B 0.00
Can-Fite Biopharma (CANF) Israel $0.027B 0.00
IsoRay (ISR) United States $0.026B 0.00
Midatech Pharma (MTP) United Kingdom $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.019B 0.00
Regulus Therapeutics (RGLS) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 27.45
Sundial Growers (SNDL) Canada $0.018B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Vical (BBI) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.014B 0.00
Hancock Jaffe Laboratories (HJLI) United States $0.014B 0.00
Bio-Path Holdings (BPTH) United States $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Iterum Therapeutics (ITRM) Ireland $0.010B 0.00
Shineco (TYHT) China $0.008B 0.00
JanOne (JAN) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00